SPOTLIGHT -
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
Suicidality and Suicide Prevention Following Brain Injury
Treating ‘Morally Objectionable’ Patients
Reframing Approaches to Schizophrenia
What Will the Future of Alzheimer Disease Treatment Look Like?
The Week in Review: June 24-28
Clinical Trials of Prescription Digital Therapeutics for Schizophrenia